| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10217770 | HPB | 2018 | 7 Pages |
Abstract
Locally advanced GBC remains a disease with poor prognosis. Chemotherapy with neoadjuvant intent in locally advanced/borderline resectable GBC showed good response rates. This resulted in curative surgical resection or disease stabilisation in significant proportion of patients. Patients who undergo definitive surgery after favourable response to NACT experience good survival.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Vikram A. Chaudhari, Vikas Ostwal, Shraddha Patkar, Arvind Sahu, Anup Toshniwal, Anant Ramaswamy, Nitin S. Shetty, Shailesh V. Shrikhande, Mahesh Goel,